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1  | BACKGROUND
1.1 | Overview of semen analysis: Diagnostic value 
and limitations
Routine semen analysis consists of measurement of volume, con-
centration, motility, morphology and vitality. This evaluation is 
extremely subjective and requires trained technicians as well as reg-
ularly performed quality assurance assessments (Douglas, Parekh, 
Kahn, Henkel, & Agarwal, 2019). The results can be affected by er-
rors due to operator inexperience and lack of standardized protocols 
(Tomlinson, 2016). A significant overlap is seen in basic semen pa-
rameters between fertile and infertile men (Nallella, Sharma, Aziz, & 
Agarwal, 2006). Therefore, traditional semen analysis cannot iden-
tify the molecular and cellular mechanisms involved in fertilization 
and fertility. Tests such as sperm penetration assay, acrosome reac-
tion and the hemizona assay have become redundant with the intro-
duction of assisted reproductive techniques such as intracytoplasmic 
sperm injection (ICSI) (Vogiatzi et al., 2013). New technologies such 
as automated semen analyzers, use of smartphones for semen test-
ing, microfluidics and proteomics fail to predict male fertility with 
100% accuracy (Segerink, Sprenkels, Oosterhuis, Vermes, & van den 
Berg, 2012). Therefore, diagnostic tools that can better discriminate 
fertile from infertile men and predict pregnancy outcome are de-
sired. The test with the greatest potential appears to be the assess-
ment of DNA integrity. Sperm lipids, proteins and nucleic acids are 
potential targets of oxidative stress because of the presence of ROS 
in all tissues (Figure 1; Tremellen, 2008). Oxidative stress is a major 
contributor of sperm DNA fragmentation (SDF) (Tremellen, 2008). 
SDF negatively impacts semen parameters and reproductive poten-
tial (Cho & Agarwal, 2017). In the last 10 years, sperm DNA integ-
rity has become a powerful and helpful marker of sperm function 
(Agarwal & Said, 2003). In this review, we describe the common 
methods to analyze sperm DNA integrity with special emphasis on 
TUNEL as a method of choice for measuring DNA fragmentation 
using bench flow cytometer. In addition, the methodology, quality 
control, challenges and the clinical implications of TUNEL in assess-
ing male infertility are also discussed.
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Abstract
Sperm DNA integrity is important for normal functions such as fertilization, implan-
tation, pregnancy and fetal development. Sperm DNA fragmentation (SDF) is more 
common in infertile men and may be responsible for poor reproductive function. 
Although there are a number of tests available to measure SDF, the terminal de-
oxynucleotidyl transferase-mediated deoxyuridine triphosphate-nick end labelling 
TUNEL) assay using flow cytometry is becoming more popular to measure the sperm 
DNA fragmentation. It is a direct test that measures both single- and double- DNA 
strand breaks. In this review, we describe the protocol, quality control and measure-
ment of sperm DNA fragmentation using a benchtop flow cytometer. We also briefly 
discuss the factors that can affect the results, challenges and clinical implications of 
TUNEL in assessing male infertility.
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1.2 | What clinical value does sperm DNA 
fragmentation testing provide?
Spermiogenesis is a complex process where the immature spermatids are 
transformed into mature spermatozoa. It is comprised of the Golgi, the cap, 
the acrosome and the flagellar (maturation) phase. There is a progressive 
condensation and compaction of chromatin with a significant reduction of 
nuclear volume, blocking of transcription and resistance of DNA to diges-
tion. These DNA modifications are correlated with the replacement of his-
tones with basic protamines and the elimination of the excessive residual 
cytoplasm. A mature and normal spermatozoon must be able to fertilize a 
mammalian oocyte in order to develop an embryo (Wdowiak & Bojar, 2016). 
Sperm DNA integrity tests are important in the clinical evaluation of male 
fertility. These tests include the sperm chromatin structure assay (SCSA) 
(Evenson, 1999), the single-cell gel electrophoresis assay (comet assay) 
(Simon, Zini, Dyachenko, Ciampi, & Carrell, 2017), the sperm chromatin 
dispersion (SCD) test (Fernández et al., 2003, 2005) and the terminal deox-
ynucleotidyl transferase-mediated deoxyuridine triphosphate-nick end la-
belling (TUNEL) assay (Sharma, Ahmad, Esteves, & Agarwal, 2016; Sharma 
et al., 2018, Sharma, Gupta, Henkel, & Agarwal, 2019).
Recently, an expert panel studied the value of including SDF in 
the	evaluation	of	infertility	(Agarwal,	Majzoub,	et	al.,	2016).	The	panel	
made practice recommendations based on different clinical scenarios 
to include SDF testing for (a) men with normal semen parameters 
and high-grade varicocele or abnormal semen parameters and low-
grade varicocele, (b) unexplained infertility, (c) recurrent pregnancy 
loss, (d) recurrent intrauterine (IUI) failures, (e) in vitro fertilization 
(IVF) and ICSI failures and (f) men with lifestyle risk factors (Agarwal, 
Majzoub,	et	al.,	2016).	Although	the	impact	of	SDF	testing	is	evident	
in the evaluation of male infertility, reproductive societies such as 
the	American	Society	for	Reproductive	Medicine	(ASRM),	European	
Association of Urology (EAU), American Urological Association (AUA) 
and National Institute of Clinical Excellence (NICE) do not recom-
mend including SDF in the routine assessment of fertility. However, 
it is extremely important to develop good methodological studies to 
standardize the utility of SDF testing in the clinical evaluation of in-
fertile men to allow the test to play a routine role in the workup of 
the infertile male.
2  | T YPES OF SPERM DNA DAMAGE
2.1 | DNA fragmentation
Oxidative stress is a major contributor of sperm DNA fragmentation in 
infertile	men	(Aitken	&	De	Iuliis,	2010;	Wright,	Milne,	&	Leeson,	2014).	
The chances to conceive naturally or by ART procedures such as IUI, 
IVF and ICSI are significantly reduced in men with high SDF.
2.2 | Abnormal chromatin compaction
Sperm chromatin is highly compacted during spermatogenesis by 
the replacement of nuclear histones with protamines. Protamines 
are basic proteins containing numerous cysteine and arginine resi-
dues that are present in small quantities in the immature germ cells 
(Frajese,	Silvestroni,	Malandrino,	&	Isidori,	1976).	This	unique	packag-
ing allows sperm cells to maintain compact structure, which confers 
stability, and occupies almost the total nucleus volume. Chromatin 
stability is essential for preserving sperm fertility potential and to 
ensure fertilization and embryonic development (Erenpreiss, Spano, 
Erenpreisa, Bungum, & Giwercman, 2006; Zini & Sigman, 2009).
F I G U R E  1  Mechanisms	of	ROS-
induced impairments in sperm functions
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2.3 | Chromosomal aberrations
Chromosomal aberrations in the germinal line are a major contribu-
tor to male infertility. Aneuploidies are examples of chromosomal 
aberrations caused by disjunction failure of homologous chromo-
somes or sister chromatids during meiosis or mitosis, respectively. 
The intratesticular environment can negatively affect the mecha-
nisms responsible for chromosome segregation during cell division 
generating abnormal chromosome even when the somatic karyotype 
is normal (Calogero, Burrello, De Palma, Barone, & Vicari, 2003). 
Chromosomal abnormalities of male gametes negatively affect 
pregnancy and implantation rates as well as fetal survival (Calogero 
et al., 2001; Rubio et al., 2001). In couples with recurrent pregnancy 
loss, the phenomenon is correlated with an increase in the rate of 
sex chromosome disomy in the spermatozoa of male partners (Rubio 
et al., 1999).
3  | C AUSES OF SPERM CHROMATIN 
DAMAGE (FIGURE 1)
3.1 | Meiotic recombination
Aneuploidies increase the risk of achieving a healthy pregnancy 
and	 obtaining	 a	 fetus	 without	 anomalies.	 Most	 of	 these	 ane-
uploidies are associated with improper meiotic recombination 
(Carrell, 2008). Topping et al. investigated meiotic progression 
and recombination rates in control males and compared it with a 
group of males with non-obstructive azoospermia (NOA) or se-
vere oligozoospermia. In the majority of cases, meiosis proceeds 
normally, until the first meiotic division; however, in about 10% of 
cases, a partial-to-complete meiotic arrest (no germ cells) was ob-
served in zygotene or pachytene stage. These meiotic errors are 
main contributory factors for male infertility. Defects in meiotic 
recombination may help explain NOA where a total meiotic arrest 
was observed as a result of synaptonemal abnormalities (Topping 
et al., 2006).
3.2 | Abortive apoptosis
Apoptosis or programmed cell death is a spontaneous event that 
occurs during the wave of seminiferous epithelium. Each of these 
4 waves is approximately 16 days, and hence, the total duration is 
64 days. Spermatogenesis involves proliferation, maturation and dif-
ferentiation that transforms an immature diploid sperm cells into ma-
ture haploid spermatozoa. During some phases of spermatogenesis, 
apoptosis	controls	sperm	production	within	testis	(Shukla,	Mahdi,	&	
Rajender, 2012). During normal spermatogenesis, excessive residual 
cytoplasm is eliminated by phagocytosis before the spermatozoa 
are released in the lumen for transport in the epididymis. Abnormal 
spermatozoa with excessive cytoplasm, which are destined to be 
eliminated, can escape apoptosis and appear in the ejaculate in a 
phenomena termed as abortive apoptosis. When the apoptotic index 
is very high (> 40%), the probability of achieving a pregnancy by IUI 
is significantly decreased, and the probability of spontaneous abor-
tions in cases of IVF or ICSI is increased. The apoptosis process is 
regulated at 3 levels:
1. At the cell membrane level—Fas receptors of tumor necrosis 
factor receptor (TNFR) family are present on the germ cells 
and Sertoli cells
2. At the cytoplasmic level—involving some proteases of the ‘cas-
pase’ family
3. At the nuclear level—there are apoptosis regulatory genes such as 
p53 and Bcl-2. If DNA damage cannot be repaired, p53 triggers 
the cell death process by inducing the binding of the Fas ligand to 
the Fas membrane receptor (Sakkas & El-Fakahany, 2018; Sakkas, 
Seli,	Bizzarro,	Tarozzi,	&	Manicardi,	2003).
3.3 | Oxidative stress
High levels of reactive oxygen species (ROS) are reported in 25% 
to	40%	of	semen	samples	from	infertile	men	(Mahfouz	et	al.,	2010).	
High levels of ROS overwhelm the antioxidant defences of the semi-
nal plasma and result in oxidative stress (OS). Leukocytes and abnor-
mal spermatozoa are the main producers of ROS. Semen samples 
may contain a variable number of leukocytes, predominantly neu-
trophils, which generate high levels of ROS (Sharma, Pasqualotto, 
Nelson, & Agarwal, 2001). Leukocytospermia is a condition when 
>1 × 106 white blood cells/ mL of semen are present (WHO, 2010). 
It is correlated with oxidative stress and reduced sperm concen-
tration, motility and morphology (Lanzafame, La Vignera, Vicari, 
& Calogero, 2009). The seminal plasma is rich in antioxidants and 
provides nutrition as well as a protective environment essential for 
sperm motility. In contrast, infertile men have reduced antioxidants 
and DNA repair enzymes (Zini & Al-Hathal, 2011).
Immature spermatozoa produce higher levels of ROS com-
pared to mature spermatozoa, inducing DNA damage in mature 
spermatozoa. This process can occur during the transit of mature 
and immature spermatozoa from the seminiferous tubules to the 
epididymis due to the close proximity of the spermatozoa (Sakkas 
& Alvarez, 2010). Spermatozoa are highly specialized cells that are 
poorly equipped with antioxidant defence mechanisms and are 
therefore more susceptible to oxidative stress, as they lack cyto-
plasm and the membrane is rich in polyunsaturated fatty acids. All 
of these changes result in a reduced fertilizing capacity, pregnancy 
loss or in some cases, genetic mutations of the embryo (Agarwal, 
Virk, Ong, & du Plessis, 2014).
3.4 | Other intrinsic and extrinsic factors
DNA damage can be due to other intrinsic (e.g. varicocele, spinal 
cord injury, diabetes) and extrinsic factors (e.g. lifestyle, infections, 
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exposure to xenobiotics) (Zini & Sigman, 2009). Other causes of 
sperm DNA damage include apoptosis, post-testicular DNA frag-
mentation due to endogenous endonuclease or by radiotherapy and 
chemotherapy (Alvarez, 2005).
Sperm DNA damage is likely a major contributing factor for in-
fertility in men with clinical varicoceles (Dieamant et al., 2017; Saleh 
et al., 2003; Wang, Zhang, Zhang, Lin, Zhang, & Zhang, 2012). In vari-
cocele patients, the number of apoptotic spermatozoa is higher com-
pared to those without varicocele (Lin, Dhabuwala, & Li, 2001). The 
presence of abnormal DNA and immature chromatin is associated with 
elevated intratesticular temperature during spermiogenesis. This can 
induce sperm DNA denaturation and damage chromatin packaging 
(Gual-Frau et al., 2015).
Sperm parameters can be compromised as a result of diabetes. 
According to Zhu et al., semen volume, motility and vitality in insu-
lin-dependent diabetes are significantly decreased (Zhu et al. 2017). 
High DNA fragmentation is reported in diabetic patients compared 
to those without diabetes and is largely attributed to increased oxi-
dative stress levels in these men (Zhu et al. 2017).
Environmental factors also contribute to sperm chromatin dam-
age and sperm abnormality. Xenobiotic, or synthetic, compounds 
can affect spermatozoa through occupational, pharmacological 
or environmental exposure. For example, benzene is a compound 
present in industrial chemical substances such as petroleum prod-
ucts. It is a toxic compound that is found in the environment as it 
comes from the emissions of gas oil, the combustion of hydrocar-
bons and cigarette smoke. It can induce DNA fragmentation and 
results	 in	 a	 reduction	 in	motility	 and	 vitality	 (Mandani,	 Desai,	 &	
Highland, 2013).
Diseases affecting the reproductive system (varicocele, prosta-
titis, epididymitis, vesiculitis), unhealthy lifestyle habits (smoking, al-
cohol, drugs), and environmental and food pollution (radiation, smog, 
industrial gases) represent the main sources of stress for spermatozoa 
(Mostafa	et	al.,	2006;	Saleh,	Agarwal,	Sharma,	Nelson,	&	Thomas,	2002;	
Wu & Cederbaum, 2003). Infertile men with varicocele have reduced 
levels of antioxidants in the semen (Abd-Elmoaty, Saleh, Sharma, & 
Agarwal, 2010). Obesity is linked with male infertility. In overweight and 
obese men, the sperm concentration, normal sperm morphology, semen 
volume and testosterone levels decrease significantly and DNA fragmen-
tation increases compared to men with normal weight (Cui et al., 2015; 
Dupont et al., 2013; Zhu et al. 2017). Therefore, identification of risk fac-
tors and accurate assessment of sperm DNA damage is important.
4  | E VALUATION OF SPERM CHROMATIN 
DAMAGE
4.1 | Overview of tests available (Table 1)
Table 1 lists the various tests that measure single or double DNA 
strand breaks. These may be direct or indirect. Direct tests that 
measure single- and double-strand breaks include TUNEL and 
the comet assay, whereas indirect tests such as SCSA and SCD 
measure the susceptibility of DNA to denaturation following acid 
treatment.
4.2 | What do these tests assess?
4.2.1 | comet assay
The comet assay measures the electrophoretic migration of small DNA 
fragments. Comet assay can be performed under neutral or alkaline 
conditions. In this assay, the cells are stained with fluorescent dyes and 
a total of 400 cells are scored by fluorescent microscopy. In the neu-
tral comet assay, the double-stranded DNA loops migrate from a dam-
aged cell and form a tail that unwinds from the supercoiled nucleus. 
This unwinding is proportional to the amount of DNA damage. When 
observed under a fluorescence microscope, it gives the characteristic 
appearance of a ‘comet’. Both single- and double-stranded DNA are 
exposed under alkaline conditions. A modified two-tailed comet assay 
(2-T comet assay) can also evaluate the single- and double-stranded 
DNA breaks (Cortés-Gutiérrez, Fernández, Dávila-Rodríguez, López-
Fernández, & Gosálvez, 2017). Consequently, the cells that have suf-
fered DNA damage appear as comets, where the tail is represented by 
fragmented DNA and the head is represented by the nucleus, while the 
control cells show a more spherical and condensed nucleus. DNA mi-
gration is a function of both the DNA size and the number of breaking 
sites, and the length of the tail increases with the damage.
The comet assay is simple, sensitive and rapid and correlates 
with	SCSA	and	TUNEL	assay	(Benchaib	et	al.,	2003;	Ribas-Maynou	
et al., 2012). Similarly, the 2-T comet assay is a fast, sensitive and 
reliable assay that can be used to quantify and characterise sperm 
DNA damage (Cortés-Gutiérrez et al., 2017). The comet assay is able 
to predict embryo development following IVF and ICSI in couples 
with	 unexplained	 infertility	 (Morris,	 Ilott,	 Dixon,	 &	 Brison,	 2002;	
Tomsu,	Sharma,	&	Miller,	2002).	The	clinical	threshold	for	diagnosing	
infertility and predicting IVF outcomes has been proposed (Lewis & 
Agbaje,	2008;	Ribas-Maynou	et	al.,	2012).
TA B L E  1   Assays used to evaluate sperm DNA fragmentation
Test Test principle
DIRECT
comet assay Evaluates the integrity of DNA, double- and 
single-strand breaks
TUNEL Assay Evaluates DNA fragmentation, double- and 
single-strand breaks
INDIRECT
SCSA Evaluates the susceptibility of sperm DNA 
to acid denaturation
SCD or Halo test Evaluates the susceptibility of sperm DNA 
to acid denaturation
AOT Evaluates double- and single-strand breaks
Abbreviations: AOT: acridine orange test; SCSA: sperm chromatin 
structure assay; SCD: sperm chromatin dispersion; TUNEL: terminal 
deoxynucleotidyl transferase dUTP nick end labelling
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4.2.2 | SCSA test
The SCSA (sperm chromatin structure assay) test is an indirect test to 
measure SDF. It measures the susceptibility of sperm DNA to dam-
age induced by acid denaturation, which is detected using metachro-
matic dye acridine orange (AO). Cells emit a green fluorescence when 
AO binds to native double-stranded DNA and red fluorescence when 
AO binds to damaged single-stranded DNA. Using a flow cytometer, 
10,000 spermatozoa are analysed within a few seconds and therefore 
this test is more rapid, robust and accurate compared to the subjec-
tive, microscopic evaluation. The accuracy of the SCSA test is 100%. 
Patients with SDF <30% were 7.1 times more likely to achieve a preg-
nancy in vivo and 2.0 times (95% CI) after ART (Bungum et al. 2004).
The percentage of spermatozoa with fragmented DNA is called the 
DNA fragmentation index or DFI. A threshold of < 30% DFI is asso-
ciated with in vivo pregnancy (Bungum, 2012; Bungum et al., 2007; 
Castilla et al., 2010; Giwercman et al., 2010). The DFI alone can pre-
dict fertility in couples undergoing IUI (Evenson & Wixon, 2006); how-
ever, the correlation between SCSA results and IVF/ ICSI outcomes is 
not strong (Collins, Barnhart, & Schlegel, 2008). ICSI is recommended 
when DFI exceeds 30% (Bungum et al., 2007).
4.2.3 | SCD test
The sperm chromatin dispersion (SCD) test is based on the assess-
ment of a central core and peripheral halo produced by the release 
of DNA loops. When spermatozoa with intact DNA are immersed 
in an agarose layer and exposed to lysing solutions, deproteinised 
nuclei or nucleoids exhibit halos of dispersed DNA. These halos 
can be observed either by bright field or fluorescence micros-
copy. Spermatozoa with DNA fragmentation do not show the halo 
(Fernández et al., 2003).
In the improved SCD test, the slides can be stained with Wright's 
stain and observed under bright field microscopy or using DAPI 
(4′,6-diamidino-2-phenylindole)	(2	µg/ml) and observed with fluores-
cence microscopy (Fernández et al., 2003; Zini et al., 2002). The SCD 
test is simple, fast and reproducible and results are comparable to 
SCSA	(Fernández	et	al.,	2005;	Muriel	et	al.,	2006)	and	TUNEL	assay	
(Agarwal,	Majzoub,	et	al.,	2016).	In	IVF	and	ICSI,	SCD	is	negatively	
correlated	with	fertilization	rate	(−0.245;	p = .045) and implantation 
rate	(−0.250;	p = .042) but not with clinical pregnancy rates or live 
birth	rates	(Muriel	et	al.,	2006;	Velez	de	la	Calle	et	al.,	2008).
4.2.4 | How does the TUNEL assay compare to the 
rest?
The TUNEL assay is the most common test used for evaluating SDF 
in spermatozoa as well as several end-point conditions in both natu-
ral and assisted reproduction (Baskaran et al., 2019). In a meta-anal-
ysis, the TUNEL was the most predictive assay for miscarriage rate, 
followed by SCSA (Robinson et al., 2012). Another meta-analysis by 
Osman et al., (Osman, Alsomait, Seshadri, El-Toukhy, & Khalaf, 2015) 
showed that the TUNEL assay was the most predictive test for birth 
rate with ART. The TUNEL test demonstrated a predictive value in 
clinical pregnancy after IVF/ ICSI, whereas both SCSA and SCD tests 
showed ‘weak’ predictive value (Cissen et al., 2016). Therefore, the 
TUNEL assay has the potential to be a robust diagnostic tool not only 
for predicting male infertility but also to understand the predictive 
ability of many other factors that may affect ART outcome related to 
achieving pregnancy.
5  | TUNEL A SSAY
5.1 | Principle of TUNEL assay
The TUNEL (terminal deoxynucleotidyl transferase-mediated de-
oxyuridine triphosphate-nick end labelling) assay is a reliable and 
sensitive method initially developed for measuring DNA damage 
in somatic cells. It was later modified for use with spermatozoa 
(Mitchell,	De	Iullis,	&	Aitken,	2011).	TUNEL	assay	uses	terminal	de-
oxynucleotidyl transferase (TdT), a polymerase that catalyses the 
addition of fluoresceinated-dUTP at the 3'-OH end of the DNA 
fragments (Figure 2). The assay shows the percentage of cells with 
damaged DNA (Agarwal, Gupta, & Sharma, 2016; Sharma, Cakar, & 
Agarwal, 2018). The fluorescence intensity of the sperm can be ex-
amined by fluorescence microscopy or by flow cytometry. Here, we 




After analyzing the sperm samples for concentration, the concentra-
tion is adjusted to 2.5 × 106 spermatozoa and the samples are di-
vided into test and negative controls. The samples are washed twice 
in phosphate-buffered saline (PBS) (Agarwal, Gupta, Du Plessis, 
et al., 2016). Samples are centrifuged at 300g to remove seminal 
plasma. After removing the supernatant, 7% (w/v) paraformaldehyde 
(PFA) prepared in PBS is added to the samples. Positive controls 
are prepared by adding PBS and washing spermatozoa twice with 
PBS. SDF is induced by adding 2% (v/v) hydrogen peroxide (H2O2) 
and incubating the sample for 1 hr at 50°C in a heating block. After 
incubation, the sample is centrifuged for 7 min at 300g to remove 
the H2O2. The sample is washed twice with PBS and the superna-
tant is then removed. One ml of PFA is added to the sperm pellet, 
‘Test’, ‘Negative’ and ‘Positive’ samples and are then centrifuged at 
400g for 7 min. The PFA is removed and 70% (v/v) ice-cold ethanol 
is	added.	The	samples	can	be	batched	and	kept	at	−20°C	(Agarwal,	
Gupta, Du Plessis, et al., 2016).
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5.2.2 | Protocol
SDF can be tested using the Apo-DIRECT™ kit (Pharmingen) 
(Agarwal, Gupta, Du Plessis, et al., 2016). Negative and positive 
controls are included in the kit. These are diploid cells derived from 
a human lymphoma cell line and are suspended in ethanol. Samples 
stored in ethanol are brought to room temperature. Kit controls 
(Negative and Positive controls), test samples and internal controls 
(spermatozoa with known amount of SDF) are washed twice with 
‘wash buffer’. The buffer is removed, samples are stained with 50 
µl of the staining, and incubation is carried out for 60 min in the 
dark. The staining solution consists of reaction buffer, TdT enzyme, 
FITC-dUTP and distilled water prepared according to the manu-
facturer's instructions. All specimens are incubated and at the end 
of the incubation, 1 ml of ‘rinse buffer’ is added and the sample 
is centrifuged twice. After discarding the supernatant, 0.5 ml of 
propidium iodide (PI)/RNase solution is added and the samples are 
ready to be tested after 30 min by flow cytometric analysis.
A total of 10,000 spermatozoa are counted. The settings are 
as follows: fluidic set at ‘slow’, flow rate of <100 cells per second. 
A blue laser at 20 mW provides an excitation at 488nm a red laser 
is powered by 14.7 mW diode red laser. It provides excitation at 
640 nm. There are two channels: FL1 measures Green fluorescence 
(480–530 nm) and FL2 measures red fluorescence (640 nm). The 
software provided by the manufacturer generates the dot plots and 
also calculates the percentage of TUNEL-positive cells (BD Accuri 
software; BD Biosciences).
Three plots and sequential gating strategy are used (Gupta, 
Sharma, & Agarwal, 2017; Figure 3). SDF is expressed as percentage 
of fragmented DNA.
The three plots used are as follows:
1. Forward scatter versus side scatter or ‘Plot 1’: Gate is drawn 
and small debris and larger nonsperm cells are excluded. This 
selects only spermatozoa with expected size or G1 population. 
Spermatozoa stained with PI with a flame-shaped gate are 
gated in the forward scatter (FSC) versus side scatter (SSC) 
plot	 (Muratori	 et	 al.,	 2008).
2. PI fluorescence and FSC or ‘Plot 2’: PI-positive events gating (G2) 
is applied to gate PI-positive events within the cells belonging to 
the G1 population. This gating selects only the PI-positive sper-
matozoa.	Debris	and	M450	apoptotic	bodies	that	 lack	nuclei	do	
not stain with PI and are excluded. TUNEL and PI staining exclude 
the	M450	bodies	(Muratori	et	al.,	2015).
3. PI-fluorescence- and FITC-fluorescence-positive gates or ‘Plot 3’. 
The TUNEL and PI-positive samples are in the upper right quad-
rant (Plot 4).
5.2.3 | Data analysis
Data analysis is done as described below:
1. Alignment strategy and data analysis: This is done in the ‘Collect’ 
tab. A file consisting of a standard sample with a known amount 
of DNA fragmentation is imported. The negative peak of the 
standard sample is applied to all samples as shown in Figure 4.
2. X-axis parameter is changed from FSC-A to FL1-A. For plot 5, the 
gate is changed to P3 in P1
3. The vertical red line is aligned to the center of the histogram. This 
equally splits the cell population (50%) on either side (Figure 4). 
This is easily accomplished by zooming on the histogram and 
aligning the red line in the middle of the peak.
4. The sample to be aligned is picked up by right clicking on the 
X-axis and clicking on the virtual gain. The blue line is aligned to 
the center of the sample peak (Figure 5).
5. Click on the ‘Preview’ and next click ‘Apply’. After choosing the 
option ‘Apply’ only to this sample only. Close and save the changes 
(Figure 6). After the sample is aligned an asterisk will appear at the 
bottom of each sample (Figure 7).
6. Each sample is aligned to its respective Negative control.
The acquired data are analysed in the ‘Analyze’ tab.
When the Analyze tab is opened for the first time, the workspace 
is empty (Gupta et al., 2017).
The plots are automatically selected from the original template. 
Original gates are used by copying the plots from the ‘Collect’ tab. 
Gating strategies set up in the Collect tab are applied in the Analyze tab.
A three-plot group for each sample is created:
F I G U R E  2   Schematic of DNA staining by TUNEL assay
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1. FSC-A versus SSC-A (Figure 8)
2. FSC-A versus FL2-A (Figure 9)
3. FL1-A versus FL2-A (Figure 10)
4. The first plot has no gating. The cell population is P9.
5. The gate in the second is ‘P9 in all events’; the population is P8.
6. The gate in the 3rd plot is ‘P8 in P9’ (in all events).
When the ‘Virtual Gain’ is applied, the FL1 axis is denoted with 
an asterisk. The percentage of DNA fragmentation is recorded from 
the FL1-A/FL2-A plot, and the file is saved (Figure 11).
To remove autofluorescence in the sample, the average %SDF for 
the ‘Negative’ sample for each patient is calculated. This value is sub-
tracted from the average value obtained from the patient ‘Test’ sample.
F I G U R E  3   Example of template setup for the analysis of the patient sample
F I G U R E  4   Representation of a ‘Standard sample alignment’
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The assay is correctly performed when two criteria are satisfied: 
1). ‘Negative’ control sample should be less than 5% (Figure 12). 
Similarly, the percentage of cells for ‘Positive’ control must be 
greater than 40% (Figure 13).
5.2.4 | Reference values
Threshold values for SDF have been established for the Accuri 
C6 and Accuri C6 Plus flow cytometer. SDF cut-off of 16.8%, high 
specificity (91.6%) and positive predictive value (91.4%) have been 
shown to discriminate between infertile and fertile men (Sharma 
et al., 2016; Figure 14a). All controls had a DNA fragmentation below 
the standard cut-off value (Figure 14b).
5.2.5 | Factors that can affect the assay
Quality control
Quality control is important and should always be done before the 
samples are analyzed. For C6 Accuri, performance of the instrument 
can be validated by measuring (a) coefficient of variation (CVs) and (b) 
using Levey–Jennings chart to track CVs. For validation of Accuri C6 
flow cytometer, 8-peak beads which are 3.2 μm spherical particles 
are used. They emit light at eight different wavelengths. One mL of 
deionised water is added to one 12 × 75 mm tube labelled as ‘8-Peak 
QC Beads’, the contents of the vial are mixed by inverting the vial a 
couple of times and four drops of the 8-peak beads are added to the 
tube.
The 8-peak QC beads measure FL1-H, FL2-H and FL3-H chan-
nels (Figure 15). These channels correspond to the four plot loca-
tions as illustrated below:
1. FSC-H versus SSC-H
2. FL1-H versus Count
3. FL2-H versus Count
4. FL3-H versus Count.
Perform the following under the collect tab:
1. Deselect the ‘time’ checkbox next to ‘min’ and ‘sec’.
2. Check he ‘events’ checkbox.
3. Check the number of events box entered as ‘50,000’.
4. Select ‘Ungated sample’ from the drop-down menu.
F I G U R E  5   Aligning a test sample to the standard sample F I G U R E  6   Applying the alignment to the test sample. This is 
indicated by an asterisk at the bottom of the histogram confirming 
the alignment of the sample to the standard file
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5. Check ‘fluidics’ speed to low.
After vortexing, run the sample to start the acquisition (Gupta 
et al., 2017).
To analyze the QC run, R1 gate is adjusted such that 75% to 85% 
of all events are contained in the R1 gate.
1. Include the main bead population, that is all singlets. This is 
done in the first plot, FSC-H versus. SSC-H plot (top-left), by 
adjusting the border of the R1 gate
2. Exclude all the light-grey dots (doublets) that are outside the dark 
black (singlet) population.
3. Gate FL1-H, FL2-H and FL3-H histograms on R1 and measure the 
CV of the brightest peak in the three histograms.
4. To meet the validation criteria, each peak must have < 5% CV. The 
data can also be displayed in Levey–Jennings plot.
Similarly, for the C6 Plus cytometer, QC can be performed using 
the BD CS&T RUO beads to check and monitor the instrument's per-
formance. The CS&T RUO beads have a known median fluorescence 
intensity	 (MFI)	 and	 distribution	 (rCV),	 and	 allow	 to	 characterise,	
track and report measurements made by the cytometer. The soft-
ware sets regions around the dim beads and the mid + bright beads 
(Sharma et al., 2019).
F I G U R E  7   Steps showing the alignment of the well with a star saved under the histogram plot
F I G U R E  8   Showing the first plot with no gating
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The system measures the brightness and distribution of 
the bright beads and compares the results to expected values. 
Instrument sensitivity is also calculated. In addition, the compen-
sation values are updated based on the CS&T RUO bead results. 
When the QC test is complete, a Pass or Fail result is displayed. The 
QC is run as per the manufacturer's instructions and the reports can 
be tracked using the Levey–Jennings plots. The graphs in the report 
show random errors or shifts and trends in the data for each pa-
rameter and help diagnose possible problems with the system. The 
graphs show the bright bead median values, percentage rCV and 
F I G U R E  9   Showing the second plot gate with P9 in all events
F I G U R E  1 0   Third plot gate showing P8 in P9 in all events
F I G U R E  11   Plot in the analyzed mode showing percentage of DNA damage
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sensitivity with standard deviations for FSC, SSC, FL1, FL2, FL3 and 
FL4. The QC Report table displays the values and Pass/Fail result 
for each parameter. If any of the results for an individual parameter 
fails, the failed parameter result appears in red and the overall in-
strument QC result fails. The samples should be run only once the 
QC report appears as Pass.
Viscous or oligozoospermic samples, accessibility of stains to 
DNA, method of sperm preparation, dead cells, number of cells 
examined and the inter- and intra-observer as well as inter- and 
intra-assay variation can influence the assay results. It is import-
ant that the staining step and incubation at 37°C is performed 
strictly for 1h, as longer incubation times will overstain the sam-
ples. The samples must be run within 3h after staining and over-
night storage of stained cells must be avoided. Concentration of 
the fixative, storage time of fixed samples, fluorochrome used and 
methodology for analyzing the data can significantly affect SDF 
(Muratori	et	al.,	2010).	The	alignment	of	the	samples	with	the	 in-
ternal ‘Standard’ sample must be carefully done in the ‘Collect’ 
tab along with the gating strategies applied in the Collect tab. This 
is necessary to avoid large variations in the final values of DNA 
fragmentation.
5.2.6 | Benchtop cytometry
Both the BD Accuri C6 and C6 Plus Systems are non-pressurised 
systems. They include an all-in-one desktop workstation running 
BD Accuri C6 or C6 Plus software. The system also includes the 
8-Peak beads for C6 and CS&T RUO beads for C6 Plus instrument 
Quality Control (Sharma et al., 2019).
The optical components for both flow cytometers consist of the 
blue laser (488 nm) and the red laser (640 nm). The optical assem-
bly consists of 4 filters: 1) FL1 (533/30 nm), 2) FL2 (585/40 nm), 3) 
FL3 > 670 LP nm and 4) FL4 (675/25 nm) filters. For TUNEL assay, 
the FL1 green channel for fluorescence isothiocyanate (FITC) stain 
and the red channel 640 nm can be used for the propidium iodide 
staining. In the centre of the four filters is the flow cell and con-
sists of a capillary where the laser intersects the sample stream. The 
C6 Plus Accuri flow cytometer also has an optional barcode reader 
that can be attached to a USB port on the computer. The two-la-
ser, six-parameter flow cytometer is composed of fluidics, optics 
and electronics systems. The fluidics system consists of peristaltic 
pumps providing a non-pressurised, ‘push/pull’ fluid system. To max-
imize light collection, optical detectors are clustered around the flow 
F I G U R E  1 2   Representative plot of ‘Negative kit control’
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F I G U R E  1 3   Representative plot of ‘Positive kit control’
F I G U R E  14   Receiver operator characteristic (ROC) curve showing (a) TUNEL assay cut-off and the area under the curve. Values within 
the parentheses represent the 95% confidence interval and (b) distribution of TUNEL test values between controls and infertile men
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cell. The electronics system provides up to 7 decades of dynamic 
range, allowing for fixed detector voltages.
Both the C6 and C6 Plus have the fluidic components comprised 
of the sheath bottle, waste bottle, detergent solution bottle and the 
BD FACS clean solution or the yellow bottle. Both cytometers in-
clude the in-line sheath filter, the sheath pump, waste pump and the 
sample injection probe (SIP). Both flow cytometers have been stan-
dardized for method comparison, precision and accuracy. Both C6 
Plus versus C6 flow cytometer have been compared for concordance 
coefficient correlation, precision, accuracy, cut-off, sensitivity and 
specificity in using the unadjusted and adjusted settings. Similarly, 
the inter- and intra-assay variation and precision of the two instru-
ments has also been compared (Sharma et al., 2019). Passing–Bablok 
regression analysis was used to test the concordance and methods 
comparison between the two instruments (Figure 16). Spermatozoa 
from patients, donors, internal positive and negative controls for 
spermatozoa were compared on the two instruments by generating 
Bland–Altman plots.
A highly significant (r = .992; 95% CI: 0.982–0.997; p < .0001) cor-
relation was seen between SDF values acquired from the adjusted 
workspace in the C6 Plus and standardised workspace for C6 flow 
cytometer	(Sharma	et	al.,	2019).	Much	smaller	differences	were	seen	
between C6 Plus adjusted and the C6 standard method, which are 
obvious from the Bland–Altman plots (Figure 17). A strong concor-
dance and high precision (98%), accuracy >99% was seen between 
the two flow cytometers. Similarly, a strong agreement between in-
ter-observers was reported on the C6 flow cytometer (rank correla-
tion coefficient = 0.922; p < .0001) and 95% CI of 0.83–0.97 (Sharma 
et al., 2019). Unadjusted C6 Plus had low sensitivity (94.4%) and spec-
ificity (80.0%) and an area under curve (AUC) of 0.90. The SDF cut-off 
was significantly lower (7.5%) than the established cut-off of 17.0% 
(Figure 18a). After adjusting the settings, the two instruments could 
predict TUNEL results with similar accuracy (Figure 18b).
The inter-observer variability on C6 Plus was small and highly cor-
related (r = .993; p < .0001) with 95% CI of 0.985–0.997. A high intra-ob-
server agreement was seen on C6 as was the inter-observer agreement 
on the C6 flow cytometer for the two observers (Sharma et al., 2019).
Many	kits	combine	the	TUNEL	assay	with	PI	to	exclude	apoptotic	
nuclear	bodies	in	the	semen	(Marchiani	et	al.,	2014).	Apoptotic	bodies	
interfere with the TUNEL analysis. Spermatozoa can be categorized 
into two distinct populations using PI staining, that is PI-dimmer pop-
ulation reflects dead spermatozoa and PI-brighter population consists 
of spermatozoa with variable fractions of live and dead spermatozoa 
(Marchiani	et	al.,	2014;	Muratori	et	al.,	2008).	The	diagnostic	power	of	
F I G U R E  1 5  8-peak	quality	control	beads	as	seen	after	analysis	in	software;	CV	of	the	brightest	peak	(M3,	M6,	M9)	is	measured
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the TUNEL test is increased by including PI. The clinical utility of PI in-
clusion is that SDF in the bright population is able to predict male fertil-
ity independently from conventional semen parameters and age. High 
SDF in this subpopulation can better discriminate infertile patients and 
fertile controls than when SDF is measured in the total sperm popula-
tion,	that	is	brighter	and	the	dimmer	population	(Muratori	et	al.,	2015).
5.3 | Common laboratory protocols between 
TUNEL and flow cytometry
It is important to standardize the TUNEL protocol using flow cytom-
eter, both in terms of the instrumentation and the kit that is used 
to stain the cells. Both direct kits such as APO-DIRECT™ kit (BD 
Pharmingen) and the In Situ Cell Death Detection, Fluorescein kit 
(Roche Diagnostics) use a direct labelling system such as fluorescein 
isothiocyanate-dUTP. Indirect kits such as Apo-BrdU In Situ DNA 
Fragmentation kit (BioVision) use an antibody-based labelling system.
In the indirect antibody-based kit, BrdUTP is used to label the DNA. 
BrdUTP binds to the 3’-OH terminals of the DNA strand breaks and TDT. 
The antibodies to the BrdUTP are tagged to the fluorescein molecule 
that is detected in the FL1 channel and propidium iodide fluorescence is 
recorded in the FL3 channel (Anzar, He, Buhr, Kroetsch, & Pauls, 2002; 
Ribeiro,	Muratori,	De	Geyter,	&	De	Geyter,	2017;	Ribeiro	et	al.,	2013).
5.4 | Challenges in using TUNEL assay to measure 
DNA integrity
Commercially available kits are commonly used for measuring DNA 
breaks. The inclusion of PI staining in TUNEL flow cytometry makes 
the TUNEL test a gold standard for SDF. However, the thresh-
old values vary greatly among different labs from 20% (Sergerie, 
Laforest, Bujan, Bissonnette, & Bleau, 2005; Sharma et al., 2010) 
to 35% (Domínguez-Fandos, Camejo, Ballescà, & Oliva, 2007; 
Sepaniak et al., 2006). This is attributed to the large differences in 
the methodologies.
Ribeiro et al., 2017 demonstrated an underestimation in the 
SDF by TUNEL test with the indirect method using fluorescent 
antibody (BrdUTP/FITC-anti-BrdUTP) compared to direct label-
ling systems. This was especially true in the PI-dimmer population 
which consisted of dead spermatozoa in the fresh semen sample 
before fixation (Ribeiro et al., 2017). The PI-brighter population 
strongly	stains	live	and	dead	spermatozoa	(Marchiani	et	al.,	2014).	
Indirect antibody-based (BrdUTP/fluorescein-anti-BrdUTP) kits 
underestimate SDF due to steric hindrance, and therefore, these 
kits are not recommended to be used to measure DNA damage 
in semen. The differences in SDF between the direct and indirect 
method ranged from 19.2% to 85.3%. Indirect labelling stained a 
lower number of cells (40.1% [23.6%, 58.2%]) compared to 65.7% 
[36.5%, 90.9%] (n = 10, p < .05) staining with the direct labelling 
(Ribeiro et al., 2017).
5.5 | Clinical implication of TUNEL assay in 
assessing male infertility
Sperm DNA fragmentation is an important tool in evaluating male 
fertility. The clinical utility of SDF is valuable in infertile men 
with clinical varicocele pre- and post-varicocelectomy, obesity, 
history of chemotherapy or radiation exposure, associated with 
high	SDF	and	 recurrent	pregnancy	 loss	 (Agarwal,	Cho,	Majzoub,	
&	 Esteves,	 2017;	 Agarwal,	 Majzoub,	 et	 al.,	 2016;	 Baskaran	
et	 al.,	 2019;	 Majzoub,	 Agarwal,	 &	 Esteves,	 2017).	 Some	 of	 the	
important clinical implications of using TUNEL assay in assessing 
male infertility are briefly described below:
F I G U R E  1 6   Passing–Bablok regression analysis showing (a) unadjusted C6 Plus versus C6 standardized and (b) adjusted C6 Plus versus 
C6 standardized. The wider deviation of the values from one another can clearly be seen
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5.5.1 | Ejaculatory Abstinence
Prolonged ejaculatory abstinence increases SDF (Agarwal, Gupta, Du 
Plessis et al., 2016). Lower SDF was seen with shorter ejaculatory ab-
stinence periods. When ejaculatory abstinence was categorized into 
short (<1 day), recommended (2–7 days) and long (>7 days), SDF in-
creased progressively. These findings validate that the direct relation-
ship between ejaculatory abstinence and DNA damage not only in men 
with normozoospermia but in men with infertility problems (Agarwal, 
Gupta, Du Plessis, et al., 2016; Borges, Braga, Zanetti, Iaconelli, 
&	 Setti,	 2019;	 Gosálvez,	 González-Martínez,	 López-Fernández,	
Fernández,	&	Sánchez-Martín,	2011;	Gosálvez	et	al.,	2011).	The	WHO	
2010 guideline still recommends 2–7 days abstinence (WHO, 2010).
5.5.2 | Varicocele
Poor sperm quality in varicocele patients is associated with oxida-
tive stress (Hendin, Kolettis, Sharma, Thomas, & Agarwal, 1999; 
F I G U R E  17   Bland–Altman plots for (a) unadjusted C6 Plus versus C6 standardized and (b) adjusted C6 Plus versus C6 standardized
F I G U R E  1 8   Receiver operating characteristic (ROC) curve showing sensitivity, specificity and cut-off for C6 Plus in (a) unadjusted SDF 
and (b) after adjustment with the standard C6 flow cytometer
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Pasqualotto et al., 2008). Increased sperm DNA fragmenta-
tion index (DFI) seen in varicocele patients is largely due to 
ROS mediated OS (Baskaran et al., 2019; Esteves, 2019; Smith 
et al., 2006). Elevated serum FSH level, higher oxidative reduc-
tion potential (ORP) and DFI values are seen in infertile men 
with varicocele compared to fertile controls. Furthermore, ORP 
and DFI was inversely related with semen parameters (Tanaka 
et al., 2020). Patients with grade 2/3 and normal conventional 
semen parameters (grade C recommendation) and patients 
with grade 1 varicocele and borderline/abnormal conventional 
semen parameter results (grade C recommendation) might be 
candidates for SDF testing (Esteves, 2019; Roaque and Esteves). 
In a recent report, lower amounts of global sperm DNA meth-
ylation were reported in men with varicocele (49.7% ± 20.7%) 
compared to controls (64.7% ± 17.1%). SDF was negatively cor-
related with sperm motility and a positively with sperm morphol-
ogy and telomere length (Nguyen, Trieu, Tran, & Luong, 2019; 
Santana et al., 2019). These findings suggest genomic instability. 
Understanding molecular mechanisms involved in pathophysiol-
ogy of varicocele-related infertility might help in selection of 
surgical candidates for varicocele correction. The effect of vari-
cocelectomy on sperm DNA damage has been extensively stud-
ied (Cho, Esteves, & Agarwal, 2019; Nguyen et al., 2019; Roque 
& Esteves, 2018; Santana et al., 2019). In a retrospective study 
consisting of 511 patients from 9 prospective and 3 retrospec-
tive studies, reduction in SDF following varicocelectomy was 
seen (Lara-Cerrillo et al., 2020; Roaque & Esteves, 2018; Zini & 
Dohle, 2011).
5.5.3 | Natural pregnancy
Improved chances of natural pregnancy are found in couples with 
lower	SDF	values	as	determined	by	both	TUNEL	and	SCSA	 (Malić	
Vončina	et	al.,	2016).	Similarly,	TUNEL	has	been	shown	to	better	pre-
dict natural pregnancy with high sensitivity and specificity (Wiweko 
B & Utami P., 2017).
In intrauterine insemination (IUI), none of the women achieved a 
pregnancy if the samples had >12% SDF measured by TUNEL assay 
(Duran, 2002).
5.5.4 | In vitro fertilization
A modest relationship between sperm DNA damage and pregnancy 
rates with IVF was reported in two systematic reviews (Collins 
et al., 2008; Zini & Sigman, 2009). The first review examined 9 IVF 
studies (6 using TUNEL and 3 SCSA) and reported lower pregnancy 
rates in patients with a high SDF (combined OR of 1.57; 95% CI, 
1.18–2.07; p < .05). The other review had 553 patients who under-
went conventional IVF, and the data showed a statistically significant 
association between SDF (measured by TUNEL, SCSA and Comet) 
and pregnancy rate (OR of 1.27; 95% CI, 1.05–1.52; p = .01) (Osman 
et al., 2015).
5.5.5 | SDF and risk of pregnancy loss after ART
High DNA damage was associated with a significant increase in 
pregnancy loss in patients compared to those with low DNA dam-
age [risk ratio (RR) =2.16 (95% CI, 1.54–3.03; p < .001)] (Robinson 
et al., 2012). Lower SDF levels have been reported with use of 
testicular spermatozoa (4.8% ± 3.6%) compared to ejaculated 
spermatozoa (23.6% ± 5.1%; p < .001), and higher pregnancy 
rates were reported in testicular spermatozoa and ICSI (44.4% 
versus 6%; p < .05) (Greco et al., 2005). Another meta-analysis 
analysed 998 couples and showed that couples whose male 
partners had low SDF achieved higher live birth rates after IVF 
(Osman et al., 2015).
Use of SDF testing has been recommended in the following 
cases: (a) patients with recurrent failures in IVF and ICSI, (b) use of 
testicular spermatozoa in men with oligozoospermia and (c) recur-
rent IVF failure (Agarwal et al., 2017; Esteves, 2019).
6  | CONCLUSION
Sperm chromatin structure assay is a proprietary technique that 
cannot be conducted in all laboratories. TUNEL is well standard-
ised by independent laboratories for inter- and intra-observer 
variability and can be performed using a readily available TUNEL 
detection kit. TUNEL appears to be the most promising method 
for measuring SDF. It can directly examine the sperm DNA strand 
breaks by measuring 10,000 cells using flow cytometry. It is 
therefore a very robust technique. Existing protocols need to be 
standardized and validated before adopting them into prospec-
tive studies or routinely in a clinical setting. The antibody-based 
system greatly underestimates SDF, especially in infertile pa-
tients with reduced sperm motility. BrdUTP/fluorescein-anti-Br-
dUTP kits should not be recommended to measure DNA damage 
in semen. It is imperative that the methodology is standardized 
across andrology laboratories worldwide to further reduce the 
variability, whether it is the choice of staining kits, instrumenta-
tion or inter- and intra-observer variability.
7  | TAKE-HOME MESSAGES
• TUNEL assay combined with flow cytometry is a promising 
method for quantification of SDF.
•	 Measuring	SDF	with	TUNEL	by	flow	cytometry	is	robust	and	can	
measure 10,000 cells very rapidly.
• Direct kits using fluorescein-dUTP are commercially available for 
the detection of SDF.
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• Indirect antibody-based (BrdUTP/fluorescein-anti-BrdUTP) kits 
underestimate SDF due to steric hindrance.
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